YU44663B - Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline - Google Patents

Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline

Info

Publication number
YU44663B
YU44663B YU21/78A YU2178A YU44663B YU 44663 B YU44663 B YU 44663B YU 21/78 A YU21/78 A YU 21/78A YU 2178 A YU2178 A YU 2178A YU 44663 B YU44663 B YU 44663B
Authority
YU
Yugoslavia
Prior art keywords
hynoxaline
obtaining
substituted imidazo
imidazo
substituted
Prior art date
Application number
YU21/78A
Other languages
English (en)
Other versions
YU2178A (en
Inventor
P L Warner
E J Luber
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of YU2178A publication Critical patent/YU2178A/xx
Publication of YU44663B publication Critical patent/YU44663B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
YU21/78A 1977-01-07 1978-01-06 Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline YU44663B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75764077A 1977-01-07 1977-01-07

Publications (2)

Publication Number Publication Date
YU2178A YU2178A (en) 1990-04-30
YU44663B true YU44663B (en) 1990-12-31

Family

ID=25048641

Family Applications (1)

Application Number Title Priority Date Filing Date
YU21/78A YU44663B (en) 1977-01-07 1978-01-06 Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline

Country Status (19)

Country Link
US (1) US4160097A (nl)
JP (2) JPS5387398A (nl)
AU (1) AU521807B2 (nl)
BE (1) BE862608A (nl)
CA (1) CA1149385A (nl)
CH (2) CH636102A5 (nl)
CS (1) CS200232B2 (nl)
DE (2) DE2858766C2 (nl)
DK (1) DK157024C (nl)
FI (1) FI64374C (nl)
FR (1) FR2376858A1 (nl)
GB (2) GB1579499A (nl)
GR (1) GR73168B (nl)
IE (1) IE46191B1 (nl)
LU (1) LU78813A1 (nl)
NL (1) NL7800114A (nl)
SE (2) SE436359B (nl)
YU (1) YU44663B (nl)
ZA (1) ZA7827B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE439308B (sv) * 1978-08-02 1985-06-10 Roussel Uclaf Imidazo(1,2-a)kinoxaliner och farmaceutiska kompositioner derav
JPS5569567A (en) * 1978-11-21 1980-05-26 Eisai Co Ltd Novel imidazole compound, and antidepressant containing the same
IT1209431B (it) * 1980-11-28 1989-07-16 Angeli Inst Spa Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.
DE3830054A1 (de) * 1988-09-03 1990-03-15 Boehringer Mannheim Gmbh Phenylamide - verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
JPH0349309U (nl) * 1989-09-21 1991-05-14
US6235740B1 (en) 1997-08-25 2001-05-22 Bristol-Myers Squibb Co. Imidazoquinoxaline protein tyrosine kinase inhibitors
US6635626B1 (en) 1997-08-25 2003-10-21 Bristol-Myers Squibb Co. Imidazoquinoxaline protein tyrosine kinase inhibitors
CN1285834A (zh) 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
DE69940808D1 (de) * 1998-03-04 2009-06-10 Bristol Myers Squibb Co Heterocyclen substituierte imidazopyrazine als protein- tyrosin-kinase-inhibitoren
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
DE60117835T2 (de) 2000-10-03 2006-10-19 Bristol-Myers Squibb Co. Amino- substituierte tetracyclische Verbindungen,die als entzündungshemmende Mittel nützlich sind, und diese enthaltende Arzneimittel
CA2436770A1 (en) * 2001-02-01 2002-08-08 James R. Burke Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk)
EP2066642A1 (en) * 2006-09-25 2009-06-10 Arete Therapeutics, INC. Soluble epoxide hydrolase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541109A (en) * 1968-06-25 1970-11-17 Du Pont 1-substituted imidazoles useful in acth reserve assay
US4011236A (en) * 1968-09-09 1977-03-08 Merck & Co., Inc. N-(benzimidazol-2-yl)arylcarboxamides as ultraviolet (uv) light absorbers
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
US3994893A (en) * 1975-11-03 1976-11-30 E. R. Squibb & Sons, Inc. 4-Amino derivatives of pyrozolo[1,5-a]quinoxaline-3-carboxylic acid and esters

Also Published As

Publication number Publication date
FI64374B (fi) 1983-07-29
FR2376858B1 (nl) 1980-10-24
FI64374C (fi) 1983-11-10
CA1149385A (en) 1983-07-05
JPS5387398A (en) 1978-08-01
DK157024B (da) 1989-10-30
DK4278A (da) 1978-07-08
SE7800138L (sv) 1978-07-08
JPH0130825B2 (nl) 1989-06-22
JPS61171470A (ja) 1986-08-02
FR2376858A1 (fr) 1978-08-04
JPS6259110B2 (nl) 1987-12-09
DK157024C (da) 1990-04-02
ZA7827B (en) 1979-01-31
SE436359B (sv) 1984-12-03
LU78813A1 (fr) 1978-09-18
DE2858766C2 (nl) 1990-04-05
SE8300945D0 (sv) 1983-02-21
GB1579498A (en) 1980-11-19
AU3233178A (en) 1979-07-19
CS200232B2 (en) 1980-08-29
IE46191B1 (en) 1983-03-23
NL7800114A (nl) 1978-07-11
BE862608A (fr) 1978-07-03
SE8300945L (sv) 1983-02-21
CH636102A5 (fr) 1983-05-13
AU521807B2 (en) 1982-04-29
US4160097A (en) 1979-07-03
YU2178A (en) 1990-04-30
CH640229A5 (fr) 1983-12-30
GB1579499A (en) 1980-11-19
SE460477B (sv) 1989-10-16
DE2800480A1 (de) 1978-07-13
FI780023A (fi) 1978-07-08
IE780037L (en) 1978-07-07
GR73168B (nl) 1984-02-14
DE2800480C2 (nl) 1990-04-12

Similar Documents

Publication Publication Date Title
YU123678A (en) Process for producing 3-(1h-tetrazo-5-yl)-4h-pyrido-(1,2-a)-pyrimidin-4-one
YU41121B (en) Process for obtaining 1-phenyl-2-azolyl-4,4-dmethyl-1-pentene-3-ole
GB1540024A (en) Process for preparing 1,4:3,6-dianhydro-d-glucitol 2-nitrate
HU178910B (en) Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines
YU44663B (en) Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline
YU40816B (en) Process for obtaining 5-aroyl-1,2 dihydro-3h-pyrrolo (1,2-a)pyrrol-1-carboxylic derivatives
GB2000137B (en) Process for the preparation of 7,8-dihydro-14-hydroxynormorphine
YU41015B (en) Process for obtainig 2-formqequinoxaline -1,4-dioxyde cyanoacetylhydrazone
GR65350B (en) Method for the preparation of 2,6-diaminonouoularins
YU221882A (en) Process for obtaining 4a, 9b-transhexahydro-gamma-carboline compounds
YU143678A (en) Process for obtaining substituted cyclopropylmethoxyanilides
DE2861204D1 (en) Process for the preparation of halogenovinyl-substituted 2-tetrahydrofuranones, selected halogenovinyl-substituted 2-tetrahydrofuranones
HU174059B (hu) Sposob poluchenija 2,3-dimetil-pentanala
YU41738B (en) Process for obtaining 1,2,4-oxadiazoline-5-one derivatives
YU219982A (en) Process for producing 2,3-dicyanopyrazine
GR65275B (en) Method for the preparation of 2,3-polymethyleno-4-oxo-4h-pyrido(1,2-a)pyrimidins
YU54178A (en) Process for obtaining 2,1,3-thiadiazine-4-one-2,2-dioxide deerivatives
DE2860211D1 (en) Process for the preparation of alpha-hydroxy-beta,beta-dimethyl-gamma-butyrolactone
YU278082A (en) Process for obtaining pyrrido(1,2-a)pyrimidine derivatives
YU42089B (en) Process for obtaining substituted 2-cyclopropyl-chromones
YU57478A (en) Process for obtaining 1,2,3-thiadiazoline-2-ide derivatives
YU122280A (en) Process for obtaining 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)-pyrimidin-4-one derivatives
IL56201A (en) Process for the preparation of 1,1-dihalogeno - 4-methyl-1,3,-pentadienes
YU243378A (en) Process for obtaining octahydro-pyrrolo-(1,2-a)-pyrazine
GB1557529A (en) Process for the preparation of 3 substituted 2,5 dioxotetrahydrofurans